Dosing and uses of Tarvil
Adult dosage forms and strengths
Dependent upon age, body weight, and medical condition; use under medical supervision
Pediatric dosage forms and strengths
Dependent upon age, body weight, and medical condition; use under medical supervision
Suggested uses of Tarvil
For the dietary management of tardive dyskinesia (TD) in males
Pineapple flavoured powdered drink mix containing leucine, valine, isoleucine, sugar, colouring and flavouring
Tarvil adverse (side) effects
Studies not conducted
Warnings
Contraindications
Diabetes, hypoglycaemia, clinically significant abnormal thyroid values, history of malabsorption syndrome, pancreatitis, amyloidosis, pernicious anemia, history of acute or chronic renal disease, history of gout or family history compatible with gouty arthritis, known or suspected history of a disorder of amino acid metabolism (other than phenylketonuria), and known or suspected history of proliferative disease such as multiple myeloma
Hepatitis is an exclusion if a screen was positive for hepatitis C antibody, hepatitis A antibody and the patient showed a Serum Glutamic Oxaloacetic Transaminase (SGAST) or Serum Glutamic Pyruvic Transaminase (SGALT) or Glutamyl Transpeptidase (GAMMA GT) of 180 or above or if the patient had a positive screen and was experiencing unexplained flu-like symptoms for a period of two weeks
Pregnancy
Cautions
Must only be used under strict medical supervision
Not intended for use as the sole source of nutrition
Not for parenteral use
Pregnancy and lactation
Pregnancy category: X
Lactation: N/A
Pregnancy categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA: Information not available.
Pharmacology of Tarvil
Kinetic info: studies not conducted
Mechanism of action
See product labeL
